发明名称 SUGAR CHAIN-RELATED GENE AND USE THEREOF
摘要 As a result of dedicated studies, the present inventors succeeded in discovering, for the first time, that fibrogenesis could be suppressed at the physiological tissue level by inhibiting sulfation at position 4 or 6 of GalNAc, which is a sugar that constitutes sugar chains. Furthermore, the present inventors conducted studies using various disease model animals, and as a result, successfully demonstrated that inhibitors of sulfation at position 4 or 6 of GalNAc had therapeutic effects on diseases caused by tissue fibrogenesis (tissue fibrogenic disorders).
申请公布号 US2017067058(A1) 申请公布日期 2017.03.09
申请号 US201615216231 申请日期 2016.07.21
申请人 STELIC INSTITUTE OF REGENERATIVE MEDICINE, STELIC INSTITUTE & CO. 发明人 YONEYAMA Hiroyuki;KOYAMA Jun;FUJII Masato
分类号 C12N15/113 主分类号 C12N15/113
代理机构 代理人
主权项 1. A tissue fibrogenesis suppressing-agent, which comprises as an ingredient an inhibitor of sulfation at position 4 or 6 of N-acetylgalactosamine.
地址 Tokyo JP